Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial

This publication has 28 references indexed in Scilit:

• Immune cell metabolism in autoimmunity
  Clinical and Experimental Immunology, 2019
• Metabolism as a Target for Modulation in Autoimmune Diseases
  Trends in Immunology, 2018
• Metformin and Autoimmunity: A “New Deal” of an Old Drug
  Frontiers in Immunology, 2018
• Metformin Suppresses Systemic Autoimmunity in Roquinsan/san Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK/mTOR/STAT3
  The Journal of Immunology, 2017
• mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation
  Immunity, 2016
• Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug
  Current Topics in Medicinal Chemistry, 2016
• Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof‐of‐Concept Trial of Metformin
  Arthritis & Rheumatology, 2015
• Normalization of CD4 ⁺ T cell metabolism reverses lupus
  Science Translational Medicine, 2015
• Metformin Attenuates Experimental Autoimmune Arthritis through Reciprocal Regulation of Th17/Treg Balance and Osteoclastogenesis
  Mediators of Inflammation, 2014
• B Cell–Specific Deficiencies in mTOR Limit Humoral Immune Responses
  The Journal of Immunology, 2013